1 Min Read
Oct 4 (Reuters) - Immunogen Inc
* Immunogen- on Oct, 4,, co disclosed that it expects to report that as of Sept. 30, 2017 it had cash and cash equivalents of about $194.9 million Source: (bit.ly/2gcIozK) Further company coverage:
All quotes delayed a minimum of 15 minutes. See here for a complete list of exchanges and delays.
© 2018 Reuters. All Rights Reserved.